Ketoprofen Extended-Release Capsules and Panitumumab Intravenous
Determining the interaction of Ketoprofen Extended-Release Capsules and Panitumumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ketoprofen
Brand name: Oruvail, Orudis, Actron, Orudis KT
Synonyms: Ketoprofen
Generic Name: panitumumab
Brand name: Vectibix
Synonyms: Panitumumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ketoprofen Extended-Release Capsules-Panixine
- Ketoprofen Extended-Release Capsules-Panixine DisperDose
- Ketoprofen Extended-Release Capsules-Panlor
- Ketoprofen Extended-Release Capsules-Panlor Tablet
- Ketoprofen Extended-Release Capsules-Panlor Tablets
- Ketoprofen Extended-Release Capsules-Panlor-DC
- Panitumumab Intravenous-Ketorolac
- Panitumumab Intravenous-Ketorolac (Systemic)
- Panitumumab Intravenous-Ketorolac Eye Drops (Multi-Dose Containers)
- Panitumumab Intravenous-Ketorolac Eye Drops (Single-Dose Containers)
- Panitumumab Intravenous-Ketorolac Injection
- Panitumumab Intravenous-Ketorolac nasal